Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21891745 | 0.89 | RNPEP (0.35) | RNPEP | |
| SCHEMBL979343 | 0.81 | METAP2 (0.40) | RNPEP | |
| SCHEMBL21175596 | 0.81 | — | — | |
| SCHEMBL26108644 | 0.81 | CA1 (0.33) | — | |
| SCHEMBL10861388 | 0.80 | — | — | |
| SCHEMBL133255 | 0.80 | — | — | |
| SCHEMBL6895344 | 0.80 | MIF (0.41) | RNPEP | |
| SCHEMBL6895345 | 0.80 | MIF (0.41) | RNPEP | |
| SCHEMBL23909350 | 0.79 | CYP3A4 (0.34) | — | |
| SCHEMBL6833546 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230021574-A1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-26 | — | — | US | disclosed |
| WO-2021100131-A1 | METHOD FOR PRODUCING ISOCYANATE | 旭化成株式会社 | 2021-05-27 | — | — | WO | disclosed |
| US-10968168-B2 | Isocyanate production method | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-04-06 | — | — | US | disclosed |
| EP-3626705-B1 | ISOCYANATE PRODUCTION METHOD | ASAHI CHEMICAL IND (JP) | 2021-03-24 | — | — | EP | disclosed |
| US-20200115327-A1 | ISOCYANATE PRODUCTION METHOD | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115327-A1 | ISOCYANATE PRODUCTION METHOD | IDH3A, ALKBH3, CPS1 | RNPEP 609/4885 |
| US-10968168-B2 | Isocyanate production method | IDH3A, ALKBH3, CPS1 | RNPEP 609/4885 |
| US-20230021574-A1 | METHOD FOR PRODUCING ISOCYANATE | CPS1, IDH3A, ALKBH3 | RNPEP 1386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.